相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Rosiglitazone disrupts endosteal bone formation during distraction osteogenesis by local adipocytic infiltration
Lichu Liu et al.
BONE (2013)
Inducible Brown Adipose Tissue, or Beige Fat, Is Anabolic for the Skeleton
Sima Rahman et al.
ENDOCRINOLOGY (2013)
PPARγ signaling and metabolism: the good, the bad and the future
Maryam Ahmadian et al.
NATURE MEDICINE (2013)
Telmisartan at 80 mg/Day Increases High-Molecular-Weight Adiponectin Levels and Improves Insulin Resistance in Diabetic Patients
Hiroko Mori et al.
ADVANCES IN THERAPY (2012)
Involvement of the Skeletal Renin-Angiotensin System in Age-Related Osteoporosis of Ageing Mice
Sa-sa Gu et al.
BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY (2012)
Wnt6, Wnt10a and Wnt10b inhibit adipogenesis and stimulate osteoblastogenesis through a β-catenin-dependent mechanism
William P. Cawthorn et al.
BONE (2012)
Rosiglitazone Inhibits Bone Regeneration and Causes Significant Accumulation of Fat at Sites of New Bone Formation
Lichu Liu et al.
CALCIFIED TISSUE INTERNATIONAL (2012)
Brown Remodeling of White Adipose Tissue by SirT1-Dependent Deacetylation of Pparγ
Li Qiang et al.
CELL (2012)
Beige Adipocytes Are a Distinct Type of Thermogenic Fat Cell in Mouse and Human
Jun Wu et al.
CELL (2012)
PPARγ agonists Induce a White-to-Brown Fat Conversion through Stabilization of PRDM16 Protein
Haruya Ohno et al.
CELL METABOLISM (2012)
Activation of AMPK-Sirt1 pathway by telmisartan in white adipose tissue: A possible link to anti-metabolic effects
Asuka Shiota et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2012)
Histologic identification of brown adipose and peripheral nerve involvement in human atherosclerotic vessels
Elizabeth Salisbury et al.
HUMAN PATHOLOGY (2012)
Structural basis for telmisartan-mediated partial activation of PPAR gamma
Yasushi Amano et al.
HYPERTENSION RESEARCH (2012)
β-Catenin Directly Sequesters Adipocytic and Insulin Sensitizing Activities but Not Osteoblastic Activity of PPARγ2 in Marrow Mesenchymal Stem Cells
Sima Rahman et al.
PLOS ONE (2012)
The Heparin-binding Domain of IGFBP-2 Has Insulin-like Growth Factor Binding-independent Biologic Activity in the Growing Skeleton
Masanobu Kawai et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Protein Phosphatase 5 Mediates Lipid Metabolism through Reciprocal Control of Glucocorticoid Receptor and Peroxisome Proliferator-activated Receptor-γ (PPARγ)
Terry D. Hinds et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Prdm16 determines the thermogenic program of subcutaneous white adipose tissue in mice
Patrick Seale et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Antidiabetic actions of a non-agonist PPARγ ligand blocking Cdk5-mediated phosphorylation
Jang Hyun Choi et al.
NATURE (2011)
Decreased osteoclastogenesis and high bone mass in mice with impaired insulin clearance due to liver-specific inactivation to CEACAM1
S. Huang et al.
BONE (2010)
Telmisartan alleviates rosiglitazone-induced bone loss in ovariectomized spontaneous hypertensive rats
L. Ma et al.
BONE (2010)
Antidiabetic Effects of IGFBP2, a Leptin-Regulated Gene
Kristina Hedbacker et al.
CELL METABOLISM (2010)
The Changed Metabolic World with Human Brown Adipose Tissue: Therapeutic Visions
Jan Nedergaard et al.
CELL METABOLISM (2010)
Telmisartan ameliorates hyperglycemia and metabolic profile in nonobese Cohen-Rosenthal diabetic hypertensive rats via peroxisome proliferator activator receptor-γ activation
Firas Younis et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2010)
Bone Loss in Diabetes: Use of Antidiabetic Thiazolidinediones and Secondary Osteoporosis
Beata Lecka-Czernik
Current Osteoporosis Reports (2010)
Chronic treatment with angiotensin AT(1) receptor antagonists reduced serum but not bone TGF-beta(1) levels in ovariectomized rats
Yong-Qi Li et al.
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY (2009)
A Selective Peroxisome Proliferator-Activated Receptor-γ Modulator, Telmisartan, Binds to the Receptor in a Different Fashion from Thiazolidinediones
Tetsuya Tagami et al.
ENDOCRINOLOGY (2009)
Angiotensin II Type 2 Receptor Blockade Increases Bone Mass
Yayoi Izu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Activation of Renin-Angiotensin System Induces Osteoporosis Independently of Hypertension
Yutaro Asaba et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2009)
PPARγ2 Nuclear Receptor Controls Multiple Regulatory Pathways of Osteoblast Differentiation From Marrow Mesenchymal Stem Cells
Keith R. Shockley et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2009)
TGF-β1-induced migration of bone mesenchymal stem cells couples bone resorption with formation
Yi Tang et al.
NATURE MEDICINE (2009)
Fat and beyond: The diverse biology of PPAR gamma
Peter Tontonoz et al.
ANNUAL REVIEW OF BIOCHEMISTRY (2008)
Angiotensin inhibition stimulates PPARγ and the release of visfatin
A. Storka et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2008)
Angiotensin II accelerates osteoporosis by activating osteoclasts
Hideo Shimizu et al.
FASEB JOURNAL (2008)
The use of nanoindentation for characterizing the properties of mineralized hard tissues: State-of-the art review
Gladius Lewis et al.
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS (2008)
PPAR-γ regulates osteoclastogenesis in mice
Yihong Wan et al.
NATURE MEDICINE (2007)
Telmisartan reduced blood pressure and HOMA-IR with increasing plasma leptin level in hypertensive and type 2 diabetic patients
Isao Usui et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2007)
Rosiglitazone induces decreases in bone mass and strength that are reminiscent of aged bone
Oxana P. Lazarenko et al.
ENDOCRINOLOGY (2007)
Hypoxic adipocytes pattern early heterotopic bone formation
Elizabeth Olmsted-Davis et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
Telmisartan prevents obesity and increases the expression of uncoupling protein 1 in diet-induced obese mice
Kana Araki et al.
HYPERTENSION (2006)
Angiotensin converting enzyme inhibitor use is associated with higher bone mineral density in elderly Chinese
H Lynn et al.
BONE (2006)
Netoglitazone is a PPAR-gamma ligand with selective effects on bone and fat
OP Lazarenko et al.
BONE (2006)
Molecular characterization of new selective peroxisome proliferator-activated receptor γ modulators with angiotensin receptor blocking activity
M Schupp et al.
DIABETES (2005)
PPARγ insufficiency enhances osteogenesis through osteoblast formation from bone marrow progenitors
T Akune et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Aging activates adipogenic and suppresses osteogenic programs in mesenchymal marrow stroma/stem cells:: the role of PPAR-γ2 transcription factor and TGF-β/BMP signaling pathways
EJ Moerman et al.
AGING CELL (2004)
Bone is a target for the antidiabetic compound rosiglitazone
SO Rzonca et al.
ENDOCRINOLOGY (2004)
Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPARγ-modulating activity
SC Benson et al.
HYPERTENSION (2004)
Blockade of the renin-angiotensin system increases adiponectin concentrations in patients with essential hypertension
M Furuhashi et al.
HYPERTENSION (2003)
Micro-CT in small animal and specimen imaging
David W. Holdsworth et al.
TRENDS IN BIOTECHNOLOGY (2002)
Selective angiotensin II receptor antagonism reduces insulin resistance in obese Zucker rats
EJ Henriksen et al.
HYPERTENSION (2001)
分享论文
